In a new study, scientists from the Hematology Department, University Hospital of Clermont-Ferrand, have successfully evaluated the analytical performance of the Yumizen G DDi 2 hemostatic immunoassay.
Six in ten people with Covid-19 still have at least one symptom a year later, a new study has found. Furthermore, symptoms that don’t clear up after 15 weeks are likely to last at least a year.
Artificial intelligence (AI) could help guide the post-treatment surveillance of non-small cell lung cancer (NSCLC) patients and improve outcomes as a result, according to a new study.
A global analysis of nearly 6 million Covid-19 deaths finds an increase in mortality at weekends compared to weekdays. Bureaucratic and reporting delays alone do not explain this, researchers report.
By comparing the infectious viral load caused by ancestral SARS-CoV-2 as well as by the Delta and Omicron variants, scientists highlight the benefits of vaccination.
A new study enables developers to determine vaccine safety via smart sensors that measure objective physiological parameters. This could end the reliance on subjective reports of study participants.
A new study has found that women’s health research remains disproportionately focused on the reproductive years, with few articles on the major causes of illness and death in women.
A major new study shows that artificial intelligence (AI) is a promising tool for breast cancer detection in screening mammography programs.
Can mobile phones increase the risk of brain cancer? A new, large study was unable to verify such concerns. However, the researchers say it might still be a good idea to cut back on smartphone time.
Reducing inflammatory mediators in the blood before surgical treatment of cardiac bacterial infection does not improve clinically relevant outcome, a new study shows.
Hospitals that boost nursing staff engagement also find they improve the retention rate for senior doctors, according to a new study from the University of Surrey.
The Covid pandemic might be responsible for a “substantial decrease” in mental wellbeing in the UK, according to new research from the University of East Anglia and University of York.
A new UK review shows that people who have had one or more doses of a coronavirus vaccine are less likely to develop long Covid than those who remain unvaccinated.
Cardiac rehabilitation can be done just as well at home as in the hospital. This is the conclusion of the most extensive research into ‘tele-rehabilitation’ to date.
Researchers from Auckland have uncovered a link between the sharpness of surgical tools such as scalpels and the risk of post-surgery infection.
Many women feel they are not being listened to about their health needs – and experience a lack of empathy around problems relating to menstruation, fertility, childbirth and menopause.
Researchers from Israel have developed a technology that rectifies the effects of underrepresentation of women in clinical trials using machine learning models.
New research has pinpointed ethnicity as a potential factor in brain tumour survival. A UK study showed that white British people who have been diagnosed with a malignant primary brain tumour appear to have an increased one-year mortality than patients from at least four other ethnic groups.
A large-scale qualitative study looks into the difficulties frontline doctors faced across two waves of the Covid-19 pandemic in the UK and Ireland since early 2020.
Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting Covid-19 virus variants and relatives that threaten future coronavirus pandemics.
Whole genome sequencing (WGS) from a single blood test picks up 31% more cases of rare genetic disorders than standard tests, shortening the ‘diagnostic odyssey’ that affected families experience, and providing huge opportunities for future research.
There has been a "positive shift" in inclusive gender practices in Covid-19 vaccine research, but there is still room for improvement, experts say. Women have been equally recruited and represented in randomised control trial research about Covid-19 vaccine safety, efficacy and effectiveness, according to a new study by The George Institute for Global Health and The Australian National…
Researchers from Cleveland Clinic have opened a novel study for a vaccine aimed at eventually preventing triple-negative breast cancer, the most aggressive and lethal form of the disease. This phase I trial is designed to determine the maximum tolerated dose of the vaccine in patients with early-stage triple-negative breast cancer and to characterize and optimize the body’s immune response. The…
A new study shows that women are underrepresented in stroke clinical trials relative to the number who have strokes in the general population. The research is published in Neurology, the medical journal of the American Academy of Neurology. “Making sure there are enough women in clinical studies to accurately reflect the proportion of women who have strokes may have implications for future…
A new series of protocols for treating patients with the most severe types of hearts attacks can reduce deaths by more than 50%, and eliminate gender disparities in care and outcomes, according to a new study by Cleveland Clinic.
